Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Immunity|June 9, 2009
Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunitySusannah D Brydges, James L Mueller, Matthew D McGeough, et al.
Annals of the Rheumatic Diseases|October 7, 2016
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)Jasmin B Kuemmerle-Deschner, Seza Ozen, Pascal N Tyrrell, et al.
Cell|February 27, 2016
NF-κB Restricts Inflammasome Activation via Elimination of Damaged MitochondriaZhenyu Zhong, Atsushi Umemura, Elsa Sanchez-Lopez, et al.
Science Translational Medicine|May 31, 2023
Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disordersMariasilvia Colantuoni, Raisa Jofra Hernandez, Emanuela Pettinato, et al.
Nature Communications|May 22, 2026
TRIM21 facilitates inflammasome assembly and contributes to autoinflammatory diseaseJessica Carriere, Chawon Yun, Sonal Khare, et al.
Nature Communications|July 1, 2026
Dual activation of NLRP3 and pyrin inflammasomes mediates host responses to the human fungal pathogen CoccidioidesKa Pui Sharon Yau, Jonathan Rodrigo Erlich, Priscila Rodriguez, et al.
Science Translational Medicine|October 8, 2010
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitisWolfgang Hueber, Dhavalkumar D Patel, Thaddeus Dryja, et al.
Blood|October 4, 2017
Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisibV Koneti Rao, Sharon Webster, Virgil A S H Dalm, et al.
Scientific Reports|August 19, 2023
JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disordersGeza Ambrus-Aikelin, Katsuyuki Takeda, Anthony Joetham, et al.
Pageof 20